25 XP   0   0   10

Champions Oncology Inc
Buy, Hold or Sell?

Let's analyse Champions Oncology Inc together

PenkeI guess you are interested in Champions Oncology Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Champions Oncology Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Champions Oncology Inc

I send you an email if I find something interesting about Champions Oncology Inc.

Quick analysis of Champions Oncology Inc (30 sec.)










What can you expect buying and holding a share of Champions Oncology Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.15
Expected worth in 1 year
$-0.82
How sure are you?
47.5%

+ What do you gain per year?

Total Gains per Share
$-0.67
Return On Investment
-13.3%

For what price can you sell your share?

Current Price per Share
$5.06
Expected price per share
$4.17 - $6.26
How sure are you?
50%

1. Valuation of Champions Oncology Inc (5 min.)




Live pricePrice per Share (EOD)

$5.06

Intrinsic Value Per Share

$-1.59 - $0.20

Total Value Per Share

$-1.74 - $0.05

2. Growth of Champions Oncology Inc (5 min.)




Is Champions Oncology Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$2m$8.5m-$7.4m-650.2%

How much money is Champions Oncology Inc making?

Current yearPrevious yearGrowGrow %
Making money-$2.4m-$779.5k-$1.6m-67.9%
Net Profit Margin-19.7%-6.0%--

How much money comes from the company's main activities?

3. Financial Health of Champions Oncology Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#903 / 1016

Most Revenue
#285 / 1016

Most Profit
#326 / 1016

Most Efficient
#498 / 1016

What can you expect buying and holding a share of Champions Oncology Inc? (5 min.)

Welcome investor! Champions Oncology Inc's management wants to use your money to grow the business. In return you get a share of Champions Oncology Inc.

What can you expect buying and holding a share of Champions Oncology Inc?

First you should know what it really means to hold a share of Champions Oncology Inc. And how you can make/lose money.

Speculation

The Price per Share of Champions Oncology Inc is $5.06. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Champions Oncology Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Champions Oncology Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.15. Based on the TTM, the Book Value Change Per Share is $-0.17 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Champions Oncology Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.19-3.7%-0.18-3.5%-0.06-1.1%-0.05-1.0%-0.13-2.7%
Usd Book Value Change Per Share-0.16-3.1%-0.17-3.3%-0.03-0.6%-0.02-0.3%-0.01-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.16-3.1%-0.17-3.3%-0.03-0.6%-0.02-0.3%-0.01-0.2%
Usd Price Per Share5.81-5.67-6.85-7.68-5.71-
Price to Earnings Ratio-7.80--7.98--411.98-1,584.03-785.36-
Price-to-Total Gains Ratio-36.72--34.40--71.59-2,198.75-1,147.68-
Price to Book Ratio-38.38-205.14-10.69-59.30--1.27-
Price-to-Total Gains Ratio-36.72--34.40--71.59-2,198.75-1,147.68-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.06
Number of shares197
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.17-0.02
Usd Total Gains Per Share-0.17-0.02
Gains per Quarter (197 shares)-33.05-3.17
Gains per Year (197 shares)-132.20-12.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-132-1420-13-23
20-264-2740-25-36
30-397-4060-38-49
40-529-5380-51-62
50-661-6700-63-75
60-793-8020-76-88
70-925-9340-89-101
80-1058-10660-102-114
90-1190-11980-114-127
100-1322-13300-127-140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%7.013.00.035.0%9.031.00.022.5%33.079.02.028.9%
Book Value Change Per Share0.04.00.00.0%6.06.00.050.0%11.09.00.055.0%19.021.00.047.5%47.063.04.041.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%1.00.0113.00.9%
Total Gains per Share0.04.00.00.0%6.06.00.050.0%11.09.00.055.0%19.021.00.047.5%47.063.04.041.2%

Fundamentals of Champions Oncology Inc

About Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Fundamental data was last updated by Penke on 2024-04-11 05:11:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Champions Oncology Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Champions Oncology Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Champions Oncology Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -21.1% means that $-0.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Champions Oncology Inc:

  • The MRQ is -21.1%. The company is making a huge loss. -2
  • The TTM is -19.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-21.1%TTM-19.7%-1.3%
TTM-19.7%YOY-6.0%-13.7%
TTM-19.7%5Y-6.0%-13.7%
5Y-6.0%10Y-35.3%+29.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.1%-199.6%+178.5%
TTM-19.7%-213.0%+193.3%
YOY-6.0%-279.3%+273.3%
5Y-6.0%-438.4%+432.4%
10Y-35.3%-605.5%+570.2%
1.1.2. Return on Assets

Shows how efficient Champions Oncology Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Champions Oncology Inc to the Biotechnology industry mean.
  • -9.4% Return on Assets means that Champions Oncology Inc generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Champions Oncology Inc:

  • The MRQ is -9.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.4%TTM-8.2%-1.2%
TTM-8.2%YOY-2.2%-6.0%
TTM-8.2%5Y-2.5%-5.7%
5Y-2.5%10Y-15.1%+12.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.4%-13.5%+4.1%
TTM-8.2%-12.9%+4.7%
YOY-2.2%-11.8%+9.6%
5Y-2.5%-14.1%+11.6%
10Y-15.1%-16.0%+0.9%
1.1.3. Return on Equity

Shows how efficient Champions Oncology Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Champions Oncology Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Champions Oncology Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Champions Oncology Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-604.2%+604.2%
TTM-604.2%YOY-10.5%-593.7%
TTM-604.2%5Y-125.2%-479.0%
5Y-125.2%10Y-142.4%+17.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM-604.2%-16.1%-588.1%
YOY-10.5%-15.1%+4.6%
5Y-125.2%-19.9%-105.3%
10Y-142.4%-20.9%-121.5%

1.2. Operating Efficiency of Champions Oncology Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Champions Oncology Inc is operating .

  • Measures how much profit Champions Oncology Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Champions Oncology Inc to the Biotechnology industry mean.
  • An Operating Margin of -21.4% means the company generated $-0.21  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Champions Oncology Inc:

  • The MRQ is -21.4%. The company is operating very inefficient. -2
  • The TTM is -17.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-21.4%TTM-17.9%-3.5%
TTM-17.9%YOY-8.1%-9.8%
TTM-17.9%5Y-5.9%-12.0%
5Y-5.9%10Y-36.1%+30.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.4%-295.1%+273.7%
TTM-17.9%-225.8%+207.9%
YOY-8.1%-288.4%+280.3%
5Y-5.9%-477.4%+471.5%
10Y-36.1%-625.6%+589.5%
1.2.2. Operating Ratio

Measures how efficient Champions Oncology Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.21 means that the operating costs are $1.21 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Champions Oncology Inc:

  • The MRQ is 1.214. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.179. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.214TTM1.179+0.035
TTM1.179YOY1.059+0.120
TTM1.1795Y1.053+0.127
5Y1.05310Y1.357-0.304
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2143.090-1.876
TTM1.1793.264-2.085
YOY1.0593.783-2.724
5Y1.0535.679-4.626
10Y1.3577.894-6.537

1.3. Liquidity of Champions Oncology Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Champions Oncology Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.60 means the company has $0.60 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Champions Oncology Inc:

  • The MRQ is 0.601. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.724. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.601TTM0.724-0.124
TTM0.724YOY1.077-0.353
TTM0.7245Y0.995-0.271
5Y0.99510Y1.080-0.086
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6013.914-3.313
TTM0.7244.220-3.496
YOY1.0775.388-4.311
5Y0.9956.045-5.050
10Y1.0806.406-5.326
1.3.2. Quick Ratio

Measures if Champions Oncology Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Champions Oncology Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.56 means the company can pay off $0.56 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Champions Oncology Inc:

  • The MRQ is 0.563. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.677. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.563TTM0.677-0.114
TTM0.677YOY1.027-0.351
TTM0.6775Y0.948-0.271
5Y0.94810Y1.021-0.073
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5633.572-3.009
TTM0.6773.998-3.321
YOY1.0275.390-4.363
5Y0.9485.969-5.021
10Y1.0216.287-5.266

1.4. Solvency of Champions Oncology Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Champions Oncology Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Champions Oncology Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.08 means that Champions Oncology Inc assets are financed with 107.7% credit (debt) and the remaining percentage (100% - 107.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Champions Oncology Inc:

  • The MRQ is 1.077. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.969. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.077TTM0.969+0.108
TTM0.969YOY0.759+0.210
TTM0.9695Y0.803+0.166
5Y0.80310Y0.843-0.040
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0770.336+0.741
TTM0.9690.334+0.635
YOY0.7590.269+0.490
5Y0.8030.366+0.437
10Y0.8430.390+0.453
1.4.2. Debt to Equity Ratio

Measures if Champions Oncology Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Champions Oncology Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Champions Oncology Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM81.088-81.088
TTM81.088YOY3.200+77.888
TTM81.0885Y18.948+62.140
5Y18.94810Y12.935+6.013
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.382-0.382
TTM81.0880.396+80.692
YOY3.2000.335+2.865
5Y18.9480.434+18.514
10Y12.9350.465+12.470

2. Market Valuation of Champions Oncology Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Champions Oncology Inc generates.

  • Above 15 is considered overpriced but always compare Champions Oncology Inc to the Biotechnology industry mean.
  • A PE ratio of -7.80 means the investor is paying $-7.80 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Champions Oncology Inc:

  • The EOD is -6.797. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.804. Based on the earnings, the company is expensive. -2
  • The TTM is -7.975. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.797MRQ-7.804+1.007
MRQ-7.804TTM-7.975+0.171
TTM-7.975YOY-411.984+404.009
TTM-7.9755Y1,584.031-1,592.006
5Y1,584.03110Y785.361+798.670
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.797-2.259-4.538
MRQ-7.804-2.569-5.235
TTM-7.975-2.664-5.311
YOY-411.984-4.120-407.864
5Y1,584.031-6.258+1,590.289
10Y785.361-6.171+791.532
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Champions Oncology Inc:

  • The EOD is -16.456. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -18.895. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 1.885. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-16.456MRQ-18.895+2.439
MRQ-18.895TTM1.885-20.780
TTM1.885YOY21.209-19.324
TTM1.8855Y33.592-31.707
5Y33.59210Y16.057+17.535
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-16.456-2.924-13.532
MRQ-18.895-3.246-15.649
TTM1.885-3.488+5.373
YOY21.209-5.620+26.829
5Y33.592-8.315+41.907
10Y16.057-8.826+24.883
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Champions Oncology Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -38.38 means the investor is paying $-38.38 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Champions Oncology Inc:

  • The EOD is -33.423. Based on the equity, the company is expensive. -2
  • The MRQ is -38.377. Based on the equity, the company is expensive. -2
  • The TTM is 205.142. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-33.423MRQ-38.377+4.954
MRQ-38.377TTM205.142-243.519
TTM205.142YOY10.694+194.448
TTM205.1425Y59.301+145.842
5Y59.30110Y-1.274+60.574
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-33.4231.851-35.274
MRQ-38.3772.090-40.467
TTM205.1422.095+203.047
YOY10.6942.844+7.850
5Y59.3013.466+55.835
10Y-1.2743.815-5.089
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Champions Oncology Inc.

3.1. Institutions holding Champions Oncology Inc

Institutions are holding 42.159% of the shares of Champions Oncology Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Battery Management Corp17.81463.9413242167300
2023-12-31NEA Management Company, LLC12.60670.6419171372000
2023-12-31Tocqueville Asset Management L.P.5.0360.0697684578191502.8778
2023-12-31Renaissance Technologies Corp0.9180.0011124791-1000-0.795
2023-12-31BlackRock Inc0.8540116097-200-0.172
2023-12-31Vanguard Group Inc0.60940828371415720.613
2023-12-31Essex Investment Management Company, LLC0.56790.085477200-28135-26.71
2023-12-31Ameriprise Financial Inc0.5520.000175044-9043-10.7543
2023-12-31Geode Capital Management, LLC0.451306134900
2023-12-31Northern Trust Corp0.33040.0001449171389744.8001
2023-12-31HighTower Advisors, LLC0.22980.00033123800
2023-12-31Bank of New York Mellon Corp0.226403077500
2023-12-31Acadian Asset Management LLC0.22580.00063069700
2023-12-31Dimensional Fund Advisors, Inc.0.1974026839-32241-54.5718
2023-12-31State Street Corporation0.195302655300
2023-12-31Bank of America Corp0.1902583000
2023-12-31Aristides Capital LLC0.0870.024311822-9800-45.3242
2023-09-30Citadel Advisors Llc0.0804010932-4483-29.0821
2023-12-31Morgan Stanley - Brokerage Accounts0.066909100-2000-18.018
2023-12-31UBS Group AG0.016402229-897-28.6948
Total 41.25574.76485608221-40595-0.7%

3.2. Funds holding Champions Oncology Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.50880.00046917100
2024-02-29Fidelity Extended Market Index0.22490.000530576-148-0.4817
2024-02-29DFA US Small Cap I0.1220.000616588-147-0.8784
2024-03-28iShares Micro-Cap ETF0.10970.0081491400
2024-02-29Vanguard Total Stock Mkt Idx Inv0.1041014148246621.1094
2023-09-30BlackRock Extended Mkt Composite0.09430.00061281400
2024-03-31BlackRock Extended Equity Market K0.08230.00041118340.0358
2024-02-29Fidelity Nasdaq Composite Index0.08060.00041095800
2024-02-29Fidelity Series Total Market Index0.05550.0001754500
2024-02-29Fidelity Total Market Index0.05520.0001750000
2024-02-29Schwab Total Stock Market Index0.05040.0002685400
2023-12-31Northern Small Cap Core K0.04970.0079675600
2023-12-31Essex Inv Mgt Micro Cap Growth0.04850.49836594-4304-39.4935
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.04340.0005590600
2023-12-31Northern Trust Extended Eq Market Idx0.03510.0005477100
2023-12-31NT Ext Equity Mkt Idx Fd - L0.03510.0004477100
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03490.0005474390.1901
2024-02-29Spartan Total Market Index Pool E0.02980.0001405600
2023-12-31NT Quality SCC US Fund - L0.02590.00763522-361-9.2969
2023-12-31NT Quality Small Cap Core0.02590.00833522-361-9.2969
Total 1.81610.5354246892-2842-1.2%

3.3. Insider Transactions

Insiders are holding 25.555% of the shares of Champions Oncology Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-12Daniel Newman MendelsonBUY10006.5
2024-01-10Daniel Newman MendelsonBUY29446.31
2024-01-08Daniel Newman MendelsonBUY10006.15
2024-01-05Daniel Newman MendelsonBUY20006.09
2024-01-03Daniel Newman MendelsonBUY5005.83
2023-12-21Daniel Newman MendelsonBUY25004.92
2023-12-19Daniel Newman MendelsonBUY50004.75
2023-10-10Daniel Newman MendelsonBUY11006.41
2023-10-05Daniel Newman MendelsonBUY20006.47
2023-10-03Daniel Newman MendelsonBUY25006.3
2023-09-29Daniel Newman MendelsonBUY40006.16
2023-09-26Daniel Newman MendelsonBUY50005.65
2023-09-21Daniel Newman MendelsonBUY50005.51
2023-09-19Daniel Newman MendelsonBUY50005.28

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Champions Oncology Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.158-0.168+6%-0.031-81%-0.016-90%-0.012-92%
Book Value Per Share---0.1510.084-280%0.631-124%0.381-140%0.251-160%
Current Ratio--0.6010.724-17%1.077-44%0.995-40%1.080-44%
Debt To Asset Ratio--1.0770.969+11%0.759+42%0.803+34%0.843+28%
Debt To Equity Ratio---81.088-100%3.200-100%18.948-100%12.935-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.186-0.179-4%-0.057-69%-0.051-72%-0.135-28%
Free Cash Flow Per Share---0.077-0.124+61%0.052-247%-0.016-79%-0.048-38%
Free Cash Flow To Equity Per Share---0.077-0.132+72%0.054-241%0.003-2886%-0.003-95%
Gross Profit Margin--1.7101.740-2%30.243-94%-61.137+3675%-29.556+1828%
Intrinsic Value_10Y_max--0.197--------
Intrinsic Value_10Y_min---1.591--------
Intrinsic Value_1Y_max---0.064--------
Intrinsic Value_1Y_min---0.187--------
Intrinsic Value_3Y_max---0.127--------
Intrinsic Value_3Y_min---0.542--------
Intrinsic Value_5Y_max---0.115--------
Intrinsic Value_5Y_min---0.871--------
Market Cap68784628.000-15%78979978.00077110830.500+2%93083545.500-15%106667394.898-26%78725318.578+0%
Net Profit Margin---0.211-0.197-6%-0.060-71%-0.060-71%-0.353+68%
Operating Margin---0.214-0.179-16%-0.081-62%-0.059-72%-0.361+68%
Operating Ratio--1.2141.179+3%1.059+15%1.053+15%1.357-10%
Pb Ratio-33.423+13%-38.377205.142-119%10.694-459%59.301-165%-1.274-97%
Pe Ratio-6.797+13%-7.804-7.975+2%-411.984+5179%1584.031-100%785.361-101%
Price Per Share5.060-15%5.8105.673+2%6.848-15%7.682-24%5.709+2%
Price To Free Cash Flow Ratio-16.456+13%-18.8951.885-1102%21.209-189%33.592-156%16.057-218%
Price To Total Gains Ratio-31.978+13%-36.718-34.400-6%-71.593+95%2198.745-102%1147.682-103%
Quick Ratio--0.5630.677-17%1.027-45%0.948-41%1.021-45%
Return On Assets---0.094-0.082-13%-0.022-77%-0.025-74%-0.151+60%
Return On Equity----6.0420%-0.1050%-1.2520%-1.4240%
Total Gains Per Share---0.158-0.168+6%-0.031-81%-0.016-90%-0.012-92%
Usd Book Value---2058000.0001143500.000-280%8578750.000-124%5300500.000-139%3476475.000-159%
Usd Book Value Change Per Share---0.158-0.168+6%-0.031-81%-0.016-90%-0.012-92%
Usd Book Value Per Share---0.1510.084-280%0.631-124%0.381-140%0.251-160%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.186-0.179-4%-0.057-69%-0.051-72%-0.135-28%
Usd Free Cash Flow---1045000.000-1684250.000+61%710500.000-247%-211900.000-80%-646225.000-38%
Usd Free Cash Flow Per Share---0.077-0.124+61%0.052-247%-0.016-79%-0.048-38%
Usd Free Cash Flow To Equity Per Share---0.077-0.132+72%0.054-241%0.003-2886%-0.003-95%
Usd Market Cap68784628.000-15%78979978.00077110830.500+2%93083545.500-15%106667394.898-26%78725318.578+0%
Usd Price Per Share5.060-15%5.8105.673+2%6.848-15%7.682-24%5.709+2%
Usd Profit---2530000.000-2432000.000-4%-779500.000-69%-692250.000-73%-1192325.000-53%
Usd Revenue--12019000.00012306000.000-2%13419000.000-10%11000750.000+9%7438000.000+62%
Usd Total Gains Per Share---0.158-0.168+6%-0.031-81%-0.016-90%-0.012-92%
 EOD+2 -6MRQTTM+15 -18YOY+5 -285Y+7 -2610Y+13 -20

4.2. Fundamental Score

Let's check the fundamental score of Champions Oncology Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.797
Price to Book Ratio (EOD)Between0-1-33.423
Net Profit Margin (MRQ)Greater than0-0.211
Operating Margin (MRQ)Greater than0-0.214
Quick Ratio (MRQ)Greater than10.563
Current Ratio (MRQ)Greater than10.601
Debt to Asset Ratio (MRQ)Less than11.077
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.094
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Champions Oncology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose5.100
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-01-312023-04-302023-07-312023-10-312024-01-31
Total Stockholder Equity 7,064-2,4284,636-2,7331,903-1,81093-2,151-2,058
Net Invested Capital  7,064-2,4284,636-2,7331,903-1,81093-2,151-2,058



Latest Balance Sheet

Balance Sheet of 2024-01-31. Currency in USD. All numbers in thousands.

Summary
Total Assets26,787
Total Liabilities28,845
Total Stockholder Equity-2,058
 As reported
Total Liabilities 28,845
Total Stockholder Equity+ -2,058
Total Assets = 26,787

Assets

Total Assets26,787
Total Current Assets13,198
Long-term Assets13,589
Total Current Assets
Cash And Cash Equivalents 4,468
Net Receivables 7,895
Other Current Assets 835
Total Current Assets  (as reported)13,198
Total Current Assets  (calculated)13,198
+/-0
Long-term Assets
Property Plant Equipment 13,069
Goodwill 335
Long-term Assets Other 185
Long-term Assets  (as reported)13,589
Long-term Assets  (calculated)13,589
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities21,969
Long-term Liabilities6,876
Total Stockholder Equity-2,058
Total Current Liabilities
Short-term Debt 1,305
Accounts payable 4,756
Other Current Liabilities 2,579
Total Current Liabilities  (as reported)21,969
Total Current Liabilities  (calculated)8,640
+/- 13,329
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt6,437
Long-term Liabilities Other 439
Long-term Liabilities  (as reported)6,876
Long-term Liabilities  (calculated)6,876
+/- 0
Total Stockholder Equity
Common Stock14
Retained Earnings -84,484
Other Stockholders Equity 82,412
Total Stockholder Equity (as reported)-2,058
Total Stockholder Equity (calculated)-2,058
+/-0
Other
Capital Stock14
Cash and Short Term Investments 4,468
Common Stock Shares Outstanding 13,594
Current Deferred Revenue13,329
Liabilities and Stockholders Equity 26,787
Net Debt 3,274
Net Invested Capital -2,058
Net Working Capital -8,771
Property Plant and Equipment Gross 23,030
Short Long Term Debt Total 7,742



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-01-312023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-04-302017-01-312016-10-312016-07-312016-04-302016-01-312015-10-312015-07-312015-04-302015-01-312014-10-312014-07-312014-04-302014-01-312013-10-312013-07-312013-04-302013-01-312012-10-312012-07-312012-04-302012-01-312011-10-312011-07-312011-04-302011-01-312010-10-312010-07-312010-04-302010-01-312009-10-312009-07-312009-04-302009-01-312008-10-312008-07-312008-04-302008-01-312007-10-312007-07-312007-04-302007-01-312006-10-312006-07-312006-04-302006-01-312005-10-312005-07-312005-04-302005-01-312004-10-312004-07-312004-04-302004-01-312003-10-312003-07-312003-04-302003-01-312002-10-312002-07-312002-04-302002-01-312001-10-312001-07-312001-04-302001-01-312000-10-312000-07-312000-04-302000-01-311999-10-311999-07-311999-04-301999-01-311998-10-311998-07-311998-04-301998-01-311997-10-311997-07-311997-04-301997-01-311996-10-311996-07-311996-04-301996-01-311995-10-31
> Total Assets 
710
790
740
760
770
780
1,000
1,040
1,370
1,300
1,330
1,350
1,240
1,380
1,350
1,430
1,420
1,500
1,416
1,435
1,210
1,114
876
844
750
673
786
732
624
508
487
453
400
352
392
367
301
263
267
267
45
21
1
1
0
21
184
184
1,220
1,974
4,651
4,572
4,224
5,010
4,620
4,620
1,924
3,421
3,932
3,336
3,634
4,884
12,650
11,801
9,872
8,865
6,922
5,145
4,225
13,012
11,693
10,670
10,502
10,471
8,867
5,678
3,311
2,833
12,047
9,848
7,582
7,145
5,777
7,849
8,044
7,546
8,011
6,467
6,492
7,095
8,078
8,391
10,239
10,911
11,265
13,362
13,947
15,075
20,751
22,820
25,760
25,260
27,591
28,108
29,296
33,584
35,378
34,390
36,364
36,151
34,311
29,906
28,294
26,787
26,78728,29429,90634,31136,15136,36434,39035,37833,58429,29628,10827,59125,26025,76022,82020,75115,07513,94713,36211,26510,91110,2398,3918,0787,0956,4926,4678,0117,5468,0447,8495,7777,1457,5829,84812,0472,8333,3115,6788,86710,47110,50210,67011,69313,0124,2255,1456,9228,8659,87211,80112,6504,8843,6343,3363,9323,4211,9244,6204,6205,0104,2244,5724,6511,9741,2201841842101121452672672633013673923524004534875086247327866737508448761,1141,2101,4351,4161,5001,4201,4301,3501,3801,2401,3501,3301,3001,3701,0401,000780770760740790710
   > Total Current Assets 
180
270
250
280
300
320
550
590
940
880
910
950
850
1,000
960
880
950
1,000
963
1,028
804
713
495
475
393
321
489
442
342
237
230
205
164
128
180
167
113
87
103
103
45
21
1
1
0
21
4
4
366
1,120
3,762
3,668
3,325
4,082
3,870
3,870
1,158
2,655
3,158
2,552
2,856
4,094
11,835
10,920
8,796
7,594
5,543
3,763
2,883
11,711
10,418
9,404
9,253
9,216
7,599
4,433
2,083
1,532
10,763
8,584
6,343
5,812
4,340
6,440
6,664
6,055
5,869
3,457
3,541
4,189
5,060
5,031
6,921
7,527
7,922
6,349
7,065
8,130
13,497
12,342
14,990
13,969
12,630
12,595
13,702
17,825
19,664
18,371
20,608
20,359
19,457
14,922
14,017
13,198
13,19814,01714,92219,45720,35920,60818,37119,66417,82513,70212,59512,63013,96914,99012,34213,4978,1307,0656,3497,9227,5276,9215,0315,0604,1893,5413,4575,8696,0556,6646,4404,3405,8126,3438,58410,7631,5322,0834,4337,5999,2169,2539,40410,41811,7112,8833,7635,5437,5948,79610,92011,8354,0942,8562,5523,1582,6551,1583,8703,8704,0823,3253,6683,7621,12036644210112145103103871131671801281642052302373424424893213934754957138041,0289631,0009508809601,000850950910880940590550320300280250270180
       Cash And Cash Equivalents 
90
150
140
70
170
90
220
120
180
550
630
680
570
690
730
640
520
700
591
594
542
433
452
438
358
283
449
400
296
196
195
167
121
85
120
127
68
53
85
85
45
21
1
1
0
21
4
4
366
1,072
3,709
3,495
3,053
2,625
1,728
1,728
394
1,479
2,572
2,088
1,263
2,941
10,457
8,839
7,119
6,482
4,754
2,916
2,161
10,769
9,563
7,365
7,572
5,812
5,891
3,052
575
182
9,357
6,760
4,157
3,293
2,585
4,463
4,328
3,488
3,295
430
660
1,062
856
1,016
1,956
3,310
3,237
2,202
2,784
3,282
8,342
6,943
8,553
7,429
4,687
3,998
4,781
8,701
9,007
8,058
10,826
11,645
10,118
4,869
5,513
4,468
4,4685,5134,86910,11811,64510,8268,0589,0078,7014,7813,9984,6877,4298,5536,9438,3423,2822,7842,2023,2373,3101,9561,0168561,0626604303,2953,4884,3284,4632,5853,2934,1576,7609,3571825753,0525,8915,8127,5727,3659,56310,7692,1612,9164,7546,4827,1198,83910,4572,9411,2632,0882,5721,4793941,7281,7282,6253,0533,4953,7091,072366442101121458585536812712085121167195196296400449283358438452433542594591700520640730690570680630550180120220901707014015090
       Short-term Investments 
30
30
30
30
30
30
30
30
30
30
0
0
0
0
0
0
110
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,005
1,017
1,017
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000001,0171,0171,00500000000000000000000000000000000000011000000030303030303030303030
       Net Receivables 
10
10
10
100
20
100
20
140
450
0
0
0
0
30
0
0
80
0
114
186
6
3
1
1
0
0
0
0
5
0
0
0
0
0
23
0
11
1
0
23
0
0
0
0
0
0
0
0
0
0
0
6
77
0
0
0
72
414
46
33
1,295
733
1,102
1,740
1,349
1,002
584
639
627
642
497
1,784
1,462
3,123
1,325
925
1,115
1,092
1,060
1,458
1,891
2,105
1,312
1,628
1,891
2,026
2,274
2,667
2,578
2,942
3,917
3,769
4,703
3,919
4,377
3,891
3,918
4,493
4,770
5,039
5,960
6,121
6,986
7,733
8,190
8,563
9,513
9,355
8,948
8,053
8,011
8,948
7,724
7,895
7,8957,7248,9488,0118,0538,9489,3559,5138,5638,1907,7336,9866,1215,9605,0394,7704,4933,9183,8914,3773,9194,7033,7693,9172,9422,5782,6672,2742,0261,8911,6281,3122,1051,8911,4581,0601,0921,1159251,3253,1231,4621,7844976426276395841,0021,3491,7401,1027331,2953346414720007760000000000023011102300000500001136186114080003000004501402010020100101010
       Inventory 
50
60
50
60
70
80
60
70
50
60
70
50
60
60
20
20
30
34
24
27
26
52
25
15
20
23
26
29
25
24
24
27
28
31
30
29
27
27
18
18
0
0
0
0
0
0
0
0
0
47
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000000000000004700000000018182727293031282724242529262320152552262724343020206060507060507060807060506050
   > Long-term Assets 
530
520
490
480
470
460
450
450
430
420
420
400
390
380
390
550
470
500
453
407
406
401
381
369
357
352
297
290
282
271
257
248
236
224
212
200
188
176
0
164
0
0
0
0
0
0
0
180
854
854
889
904
898
928
0
750
766
766
774
784
778
790
815
881
1,076
1,271
1,379
1,382
1,342
1,301
1,274
1,266
1,249
1,255
1,268
1,245
1,228
1,301
1,284
1,264
1,239
1,333
1,437
1,409
1,380
1,491
2,142
3,010
2,951
2,906
3,018
3,360
3,318
3,384
3,343
7,013
6,882
6,945
7,254
10,478
10,770
11,291
14,961
15,513
15,594
15,759
15,714
16,019
15,756
15,792
14,854
14,984
14,277
13,589
13,58914,27714,98414,85415,79215,75616,01915,71415,75915,59415,51314,96111,29110,77010,4787,2546,9456,8827,0133,3433,3843,3183,3603,0182,9062,9513,0102,1421,4911,3801,4091,4371,3331,2391,2641,2841,3011,2281,2451,2681,2551,2491,2661,2741,3011,3421,3821,3791,2711,076881815790778784774766766750092889890488985485418000000001640176188200212224236248257271282290297352357369381401406407453500470550390380390400420420430450450460470480490520530
       Property Plant Equipment 
520
500
490
470
460
450
440
440
420
410
400
390
380
370
380
370
360
300
342
345
345
340
320
308
296
291
286
279
271
260
246
237
225
213
201
189
177
165
153
153
0
0
0
0
0
0
0
0
0
0
0
0
0
0
81
81
97
97
105
115
109
121
146
212
257
452
560
525
485
442
413
404
387
421
434
411
395
469
452
445
420
514
618
590
561
672
1,216
2,084
2,025
1,980
2,083
2,425
2,535
2,578
2,546
6,216
6,085
6,148
6,791
10,107
10,399
10,920
14,611
15,092
15,244
15,409
15,364
15,669
15,406
15,442
14,504
14,465
13,757
13,069
13,06913,75714,46514,50415,44215,40615,66915,36415,40915,24415,09214,61110,92010,39910,1076,7916,1486,0856,2162,5462,5782,5352,4252,0831,9802,0252,0841,2166725615906185144204454524693954114344213874044134424855255604522572121461211091151059797818100000000000000153153165177189201213225237246260271279286291296308320340345345342300360370380370380390400410420440440450460470490500520
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
662
662
662
662
662
662
662
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
335
335
335
335
335
335
335
335
335
335
335
335
335
335
335
335
33533533533533533533533533533533533533533533533566966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966966266266266266266266200000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
180
180
192
192
227
242
237
266
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
669
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000006696696696696696696696696696696696696696696696696696696696696696696696696696696696696696696696696696696696696696696692662372422271921921801800000000000000000000000000000000000000000000000
       Long-term Assets Other 
10
20
10
10
10
10
10
10
10
10
20
10
10
10
10
10
10
200
111
61
61
61
61
61
61
61
11
11
11
11
11
11
11
11
11
11
11
11
11
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
150
150
150
188
188
190
192
193
193
165
165
165
164
163
163
150
150
150
150
150
150
150
257
257
257
257
266
266
114
137
128
128
128
128
128
36
36
36
15
86
15
15
15
15
15
15
15
184
185
185
1851851841515151515151586153636361281281281281281371142662662572572572571501501501501501501501631631641651651651931931921901881881501501500000000000000000000000001111111111111111111111111111616161616161611112001010101010102010101010101010102010
> Total Liabilities 
270
360
310
300
280
360
350
340
410
380
390
390
370
520
460
520
490
600
525
552
487
732
725
727
630
633
791
807
663
653
697
710
505
493
485
489
486
714
633
633
691
695
671
688
357
377
445
445
394
463
1,014
996
770
2,057
2,704
2,704
1,641
1,695
2,355
2,062
2,247
2,689
12,631
12,793
12,259
12,245
12,200
10,982
11,409
3,677
4,089
4,683
6,363
5,985
5,670
5,239
5,169
6,970
3,988
3,945
3,480
4,886
5,539
4,673
4,839
5,506
7,611
6,177
6,120
6,623
8,103
7,789
8,247
8,588
9,027
11,634
11,833
11,898
15,433
17,307
18,867
17,393
20,163
20,570
21,225
24,348
26,282
25,407
27,192
29,087
29,675
28,003
28,201
28,845
28,84528,20128,00329,67529,08727,19225,40726,28224,34821,22520,57020,16317,39318,86717,30715,43311,89811,83311,6349,0278,5888,2477,7898,1036,6236,1206,1777,6115,5064,8394,6735,5394,8863,4803,9453,9886,9705,1695,2395,6705,9856,3634,6834,0893,67711,40910,98212,20012,24512,25912,79312,6312,6892,2472,0622,3551,6951,6412,7042,7042,0577709961,014463394445445377357688671695691633633714486489485493505710697653663807791633630727725732487552525600490520460520370390390380410340350360280300310360270
   > Total Current Liabilities 
200
300
260
260
250
330
330
320
380
350
360
370
350
500
420
480
460
500
496
527
465
714
712
716
619
625
783
801
658
649
693
709
504
492
485
489
486
714
633
633
691
695
671
688
357
377
445
445
394
463
1,014
996
770
2,057
2,704
2,704
1,422
1,399
2,090
1,973
2,200
2,689
3,500
3,839
3,416
3,468
3,486
2,553
2,928
2,684
3,043
2,175
3,269
3,737
3,659
3,383
3,938
6,262
3,796
3,759
3,265
4,647
5,306
4,426
4,598
5,272
7,447
6,020
5,818
6,177
7,482
6,885
7,332
7,704
8,025
7,930
8,253
8,446
12,085
11,085
12,754
11,414
11,199
11,676
12,465
15,499
17,479
16,620
18,736
20,797
21,733
20,382
20,950
21,969
21,96920,95020,38221,73320,79718,73616,62017,47915,49912,46511,67611,19911,41412,75411,08512,0858,4468,2537,9308,0257,7047,3326,8857,4826,1775,8186,0207,4475,2724,5984,4265,3064,6473,2653,7593,7966,2623,9383,3833,6593,7373,2692,1753,0432,6842,9282,5533,4863,4683,4163,8393,5002,6892,2001,9732,0901,3991,4222,7042,7042,0577709961,014463394445445377357688671695691633633714486489485492504709693649658801783625619716712714465527496500460480420500350370360350380320330330250260260300200
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
13
13
13
13
15
14
12
9
2
4
4
4
0
4
0
0
0
0
0
260
0
0
0
0
0
19
37
44
44
44
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
57
0
0
0
0
0
0
2,000
0
0
0
0
0
0
0
0
63
58
55
49
29
137
142
224
16
466
479
667
628
587
623
628
818
854
930
1,014
1,054
1,099
1,133
1,166
1,208
1,244
1,275
1,305
1,3051,2751,2441,2081,1661,1331,0991,0541,014930854818628623587628667479466162241421372949555863000000002,000000000570000000000000000000000444444371900000260000004044429121415131313130100000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
58
55
49
42
285
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000285424955586300000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
70
90
50
50
50
40
50
50
120
40
40
50
50
130
40
100
80
100
48
70
23
118
126
122
102
60
88
137
89
35
65
66
74
61
93
92
81
68
69
69
87
71
33
32
33
22
50
50
43
112
148
189
308
696
1,414
1,414
1,185
886
944
1,109
1,382
2,082
1,580
1,498
1,294
1,623
1,676
1,291
1,209
1,101
1,204
976
982
937
981
1,328
1,632
1,362
1,414
1,436
1,338
1,515
1,896
1,509
1,152
1,324
1,852
1,732
1,549
1,961
2,154
2,119
2,021
2,116
2,807
2,725
2,787
2,215
3,140
2,675
3,948
1,745
1,894
3,345
3,477
3,743
2,868
2,537
4,605
4,298
5,334
5,759
4,536
4,756
4,7564,5365,7595,3344,2984,6052,5372,8683,7433,4773,3451,8941,7453,9482,6753,1402,2152,7872,7252,8072,1162,0212,1192,1541,9611,5491,7321,8521,3241,1521,5091,8961,5151,3381,4361,4141,3621,6321,3289819379829761,2041,1011,2091,2911,6761,6231,2941,4981,5802,0821,3821,1099448861,1851,4141,41469630818914811243505022333233718769696881929361746665358913788601021221261182370481008010040130505040401205050405050509070
       Other Current Liabilities 
130
210
210
210
200
290
280
270
260
310
320
320
300
370
380
380
370
400
435
443
430
583
506
515
448
556
569
571
511
575
628
575
430
430
392
397
405
350
565
564
604
624
638
350
287
312
351
351
351
351
361
807
462
1,430
1,290
67
106
205
236
309
244
246
302
264
223
344
625
344
514
566
611
340
329
705
587
390
546
591
373
416
283
257
271
220
302
327
685
551
390
365
595
366
341
641
1,180
770
841
978
2,502
2,154
1,995
2,426
2,231
1,996
1,926
2,041
2,486
2,099
1,813
2,175
2,415
2,237
2,171
2,579
2,5792,1712,2372,4152,1751,8132,0992,4862,0411,9261,9962,2312,4261,9952,1542,5029788417701,180641341366595365390551685327302220271257283416373591546390587705329340611566514344625344223264302246244309236205106671,2901,430462807361351351351351312287350638624604564565350405397392430430575628575511571569556448515506583430443435400370380380370300320320310260270280290200210210210130
   > Long-term Liabilities 
70
60
50
40
30
30
20
20
30
30
30
20
20
20
40
40
30
100
29
25
22
19
13
11
11
8
7
6
5
4
4
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
250
219
296
265
89
47
0
9,131
8,954
8,843
8,777
8,714
8,429
8,481
993
1,046
2,508
3,094
2,248
2,011
1,856
1,231
708
192
186
215
239
233
247
241
234
164
157
302
446
621
904
915
884
1,002
3,704
3,580
3,452
3,348
6,222
6,113
5,979
8,964
8,894
8,760
8,849
8,803
8,787
8,456
8,290
7,942
7,621
7,251
6,876
6,8767,2517,6217,9428,2908,4568,7878,8038,8498,7608,8948,9645,9796,1136,2223,3483,4523,5803,7041,0028849159046214463021571642342412472332392151861927081,2311,8562,0112,2483,0942,5081,0469938,4818,4298,7148,7778,8438,9549,13104789265296219250000000000000000000000111445678111113192225291003040402020203030302020303040506070
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148
95
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000951480000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,159
8,159
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000008,1598,159000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17
16
15
14
12
11
11
11
9
7
6
5
4
4
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
250
219
77
77
47
47
0
972
795
684
618
555
270
322
993
1,046
2,508
3,094
2,248
2,011
1,856
1,231
610
101
100
147
175
174
193
193
191
126
124
273
423
606
756
820
884
1,002
151
151
151
178
178
181
181
181
242
235
231
391
660
624
588
551
514
0
0
005145515886246603912312352421811811811781781511511511,0028848207566064232731241261911931931741751471001016101,2311,8562,0112,2483,0942,5081,046993322270555618684795972047477777219250000000000000000000000001445679111111121415161700000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
795
684
0
0
0
0
0
0
0
0
2,248
2,011
1,856
1,231
0
0
0
0
0
0
0
0
0
0
0
0
0
0
605
669
733
851
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000851733669605000000000000001,2311,8562,0112,24800000000684795000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
440
440
440
470
490
420
650
690
970
920
940
960
870
850
890
900
920
900
892
883
723
382
151
117
120
39
-5
-76
-39
-145
-210
-257
-104
-140
-93
-122
-185
-451
0
-367
-646
-674
-671
-688
-357
-356
0
-261
825
1,510
3,638
3,576
3,454
2,953
1,916
1,916
283
1,726
1,577
1,274
1,387
2,195
19
-992
-2,387
-3,380
-5,278
-5,837
-7,184
9,335
7,604
5,987
4,139
4,486
3,197
439
-1,858
-4,137
8,059
5,903
4,102
2,259
238
3,176
3,205
2,040
400
290
372
472
-25
602
1,992
2,323
2,238
1,728
2,114
3,177
5,318
5,513
6,893
7,867
7,428
7,538
8,071
9,236
9,096
8,983
9,172
7,064
4,636
1,903
93
-2,058
-2,058931,9034,6367,0649,1728,9839,0969,2368,0717,5387,4287,8676,8935,5135,3183,1772,1141,7282,2382,3231,992602-254723722904002,0403,2053,1762382,2594,1025,9038,059-4,137-1,8584393,1974,4864,1395,9877,6049,335-7,184-5,837-5,278-3,380-2,387-992192,1951,3871,2741,5771,7262831,9161,9162,9533,4543,5763,6381,510825-2610-356-357-688-671-674-646-3670-451-185-122-93-140-104-257-210-145-39-76-539120117151382723883892900920900890850870960940920970690650420490470440440440
   Common Stock
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
10
-500
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
17
17
17
17
17
17
17
17
18
27
28
28
32
32
33
33
33
33
34
34
34
37
37
37
37
37
37
37
37
38
38
38
38
39
39
39
39
70
70
70
70
70
108
9
9
9
9
11
11
11
11
11
11
11
11
11
11
12
12
12
12
12
13
13
13
13
13
13
14
14
14
14
14
14
14
14
14
14
141414141414141414141313131313131212121212111111111111111111119999108707070707039393939383838383737373737373737343434333333333232282827181717171717171717999999999999999999-5001010101010101010101010101010101010
   Retained Earnings -84,484-81,954-79,883-77,317-74,756-72,317-72,301-71,982-71,638-72,425-72,702-72,530-71,857-72,597-72,598-72,673-70,625-71,032-71,339-70,698-70,445-70,076-70,344-70,826-70,193-70,118-70,024-69,350-66,925-65,517-65,012-62,466-59,892-57,481-54,933-52,020-48,350-45,564-42,446-38,880-36,617-36,023-33,704-31,473-29,425-28,440-26,466-25,143-22,593-20,869-18,519-16,482-13,740-13,325-13,271-12,680-12,128-11,344-9,757-9,757-8,091-7,468-7,236-7,069-6,630-7,241-7,104-7,104-7,008-6,971-6,952-6,934-6,937-6,909-6,630-6,630-6,635-6,369-6,305-6,276-6,086-6,042-6,194-6,147-6,082-5,976-6,013-5,937-5,858-5,757-5,760-5,726-5,496-5,154-4,994-4,986-5,000-4,950-4,970-4,990-5,030-5,010-4,920-4,940-4,960-4,910-5,190-5,230-5,450-5,390-5,410-5,440-5,440-5,380
   Accumulated Other Comprehensive Income 0000000000-3,956-3,9560-3,356-3,048-2,772-2,526-2,307-2,256-2,074-1,901-1,737-1,586-1,468-1,359-1,254-1,164-1,122-1,081-1,041-999-954-912-874-836-798-754-698-644-588-124-124-111-100-99-98-100-125-67-53-60-68-18-30-31-4-8-2-4-40-755-801-1,042-418-427-330-4400000-925-925-925-80-925-925-961-949-937-925-913-901-889-876-864-852-840-828-818-805-793-781-800-760-740-730-740-730-710-700-690-670-660-640-640-620-610-600-580-560
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,802
19,750
0
0
0
0
0
0
0
0
42,409
43,259
44,067
44,888
45,388
61,223
62,079
62,826
63,394
0
69,429
69,963
70,206
70,991
71,555
71,732
71,906
72,070
72,187
72,057
72,756
72,924
73,055
73,134
73,790
77,978
78,098
79,477
79,711
79,945
80,227
0
80,860
81,064
81,270
81,475
81,806
82,013
0
0
0
00082,01381,80681,47581,27081,06480,860080,22779,94579,71179,47778,09877,97873,79073,13473,05572,92472,75672,05772,18772,07071,90671,73271,55570,99170,20669,96369,429063,39462,82662,07961,22345,38844,88844,06743,25942,4090000000019,75018,802000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-1,252-292-292-250-219-188-188-157-1000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
6,370
6,450
6,470
6,480
6,490
6,500
6,510
6,530
6,540
6,560
6,570
6,580
6,600
6,610
6,600
6,600
6,620
6,700
6,119
6,131
6,143
6,155
6,166
6,178
6,190
6,222
6,269
6,286
6,298
6,310
6,322
6,335
6,518
6,538
6,775
6,775
5,922
6,767
0
6,847
5,922
5,922
5,922
5,922
6,596
6,669
0
6,849
8,461
8,527
11,715
11,580
11,643
11,011
0
11,643
11,595
13,825
14,224
14,508
14,705
15,916
16,532
17,550
18,498
19,242
19,952
20,691
21,316
38,820
39,210
39,763
40,247
41,157
42,007
43,459
44,334
44,890
60,769
61,663
62,448
63,054
63,649
69,176
69,752
70,035
70,861
71,467
71,734
72,013
72,286
72,521
73,794
74,657
74,998
75,311
75,441
76,316
80,750
81,146
82,833
79,711
83,901
80,227
80,482
80,860
81,064
81,270
81,475
81,806
81,939
81,772
82,033
82,412
82,41282,03381,77281,93981,80681,47581,27081,06480,86080,48280,22783,90179,71182,83381,14680,75076,31675,44175,31174,99874,65773,79472,52172,28672,01371,73471,46770,86170,03569,75269,17663,64963,05462,44861,66360,76944,89044,33443,45942,00741,15740,24739,76339,21038,82021,31620,69119,95219,24218,49817,55016,53215,91614,70514,50814,22413,82511,59511,643011,01111,64311,58011,7158,5278,4616,84906,6696,5965,9225,9225,9225,9226,84706,7675,9226,7756,7756,5386,5186,3356,3226,3106,2986,2866,2696,2226,1906,1786,1666,1556,1436,1316,1196,7006,6206,6006,6006,6106,6006,5806,5706,5606,5406,5306,5106,5006,4906,4806,4706,4506,370



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-04-30)

Gross Profit (+$)
totalRevenue53,870
Cost of Revenue-29,532
Gross Profit24,33824,338
 
Operating Income (+$)
Gross Profit24,338
Operating Expense-28,787
Operating Income-4,449-4,449
 
Operating Expense (+$)
Research Development11,545
Selling General Administrative10,240
Selling And Marketing Expenses7,002
Operating Expense28,78728,787
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-4,449
Net Interest Income0
Other Non-Operating Income Expenses-11
Income Before Tax (EBT)-5,267-3,631
EBIT - interestExpense = -4,449
-5,267
-5,335
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-4,449-5,267
Earnings Before Interest and Taxes (EBITDA)-1,396
 
After tax Income (+$)
Income Before Tax-5,267
Tax Provision-68
Net Income From Continuing Ops-5,335-5,335
Net Income-5,335
Net Income Applicable To Common Shares-5,335
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses58,319
Total Other Income/Expenses Net-81811
 

Technical Analysis of Champions Oncology Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Champions Oncology Inc. The general trend of Champions Oncology Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Champions Oncology Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Champions Oncology Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.5 < 6.25 < 6.26.

The bearish price targets are: 4.765 > 4.5101 > 4.17.

Tweet this
Champions Oncology Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Champions Oncology Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Champions Oncology Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Champions Oncology Inc.

Champions Oncology Inc Daily Moving Average Convergence/Divergence (MACD) ChartChampions Oncology Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Champions Oncology Inc. The current adx is .

Champions Oncology Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Champions Oncology Inc.

Champions Oncology Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Champions Oncology Inc.

Champions Oncology Inc Daily Relative Strength Index (RSI) ChartChampions Oncology Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Champions Oncology Inc.

Champions Oncology Inc Daily Stochastic Oscillator ChartChampions Oncology Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Champions Oncology Inc.

Champions Oncology Inc Daily Commodity Channel Index (CCI) ChartChampions Oncology Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Champions Oncology Inc.

Champions Oncology Inc Daily Chande Momentum Oscillator (CMO) ChartChampions Oncology Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Champions Oncology Inc.

Champions Oncology Inc Daily Williams %R ChartChampions Oncology Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Champions Oncology Inc.

Champions Oncology Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Champions Oncology Inc.

Champions Oncology Inc Daily Average True Range (ATR) ChartChampions Oncology Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Champions Oncology Inc.

Champions Oncology Inc Daily On-Balance Volume (OBV) ChartChampions Oncology Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Champions Oncology Inc.

Champions Oncology Inc Daily Money Flow Index (MFI) ChartChampions Oncology Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Champions Oncology Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Champions Oncology Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Champions Oncology Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose5.100
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Champions Oncology Inc with someone you think should read this too:
  • Are you bullish or bearish on Champions Oncology Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Champions Oncology Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Champions Oncology Inc

I send you an email if I find something interesting about Champions Oncology Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Champions Oncology Inc.

Receive notifications about Champions Oncology Inc in your mailbox!